QVT Financial logo

QVT Financial

North America, New York, United States, New York

Description

QVT Financial LP is a privately owned hedge fund sponsor. The firm provides its services to pooled investment vehicles. It invests in the

Investor Profile

QVT Financial has made 28 investments, with 3 in the past 12 months and 14% as lead.

Stage Focus

  • Series C (18%)
  • Post Ipo Equity (18%)
  • Series A (18%)
  • Series Unknown (11%)
  • Series B (11%)
  • Private Equity (7%)
  • Series D (7%)
  • Pre Seed (4%)
  • Convertible Note (4%)
  • Seed (4%)

Country Focus

  • United States (82%)
  • United Kingdom (7%)
  • Canada (4%)
  • France (4%)
  • Israel (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
  • Therapeutics
  • Life Science
  • Clinical Trials
  • Manufacturing
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does QVT Financial frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
TVM Capital
Europe, Bayern, Germany, Munich
Co-Investments: 5
Three Arch Partners
North America, California, United States, Portola Valley
Co-Investments: 5
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 3
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 4
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 7
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 3
Dexcel Pharma
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 5
Venrock
North America, California, United States, Palo Alto
Co-Investments: 6
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 3

Which angels does QVT Financial often collaborate with?

PM
North America, Virginia, United States, Charlottesville
Shared Deals: 1
RB
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by QVT Financial?

QuEra Computing

Boston, Massachusetts, United States

QuEra Computing is a neutral-atoms-based quantum computing startup, located in Boston, near Harvard University.

ComputerConsumer ResearchQuantum Computing
Convertible NoteFeb 11, 2025
Amount Raised: $230,000,000
Lightsynq

Brighton, Massachusetts, United States

Lightsynq develops universal optical quantum interconnects that bridge the gap to large-scale quantum computers.

Information TechnologyQuantum ComputingWeb Development
Series ANov 19, 2024
Amount Raised: $18,000,000
Active Surfaces

Salem, Massachusetts, United States

Active Surfaces offers ultra-thin-film solar technology that can be applied to any surface.

ManufacturingRenewable EnergySolar
Pre SeedMay 13, 2024
Amount Raised: $5,600,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series CMay 16, 2022
Amount Raised: $270,000,000
Tourmaline Bio

New York, New York, United States

Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve and prevent immune diseases.

BiotechnologyClinical TrialsTherapeutics
SeedMay 1, 2022
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series BJul 14, 2021
Amount Raised: $100,000,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series AMay 12, 2020
Amount Raised: $80,500,000
Roivant Sciences

New York, New York, United States

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

BiopharmaBiotechnologyHealth CarePharmaceuticalProduct Research
Private EquityNov 13, 2018
Amount Raised: $200,000,000
Akari Therapeutics

London, England, United Kingdom

Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics.

BiopharmaBiotechnologyHealth CareTherapeutics
Post Ipo EquitySep 21, 2015
Amount Raised: $75,000,000
AveXis

Dallas, Texas, United States

AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.

BiotechnologyGeneticsHealth CareMedical
Series DSep 8, 2015
Amount Raised: $65,000,000